PregLem Company

PregLem is a Swiss biopharmaceutical company that focuses on developing and selling innovative drugs for women's reproductive medicine.

Last Funding Date: 2007-12-04
Investors Number: 4
Industry: Reproductive Health & Contraception
Funding Status: M&A
Employee Number: 11-50
Headquarters: Geneva
Last Funding Type: Series B
Total Funding: $58,248,124
Founded Date: 2006